Skip to content
Clinical Trials – home
Verifiedinfo

Vseobecna Fakultni Nemocnice V Praze

Czechia Karlovo Namesti 554/32, Nove Mesto, 120 00 Prague, Czechia

  • 150 trials recruiting
  • Plasma cell myeloma · Pulmonary arterial hypertension · Ovarian cancer
  • Adults and children

About Specializations

Vseobecna Fakultni Nemocnice V Praze in Prague, Czechia specialises in clinical trials of conditions such as Plasma cell myeloma, Pulmonary arterial hypertension, Ovarian cancer, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory and Pediatric Allergy Research

At Vseobecna Fakultni Nemocnice V Praze, clinical trials in respiratory tract diseases focus on asthma in children, with an emphasis on improving symptom control and lung function through new treatment options.

  • Evaluating whether newer inhaled therapies can improve breathing outcomes in pediatric asthma
  • Comparing treatment effectiveness to support better long-term disease management

This area of research aims to strengthen care for young patients living with chronic airway disease.

Inflammatory Bowel Disease Studies

The site also supports research in immune system diseases and digestive system disorders, especially Crohn's disease in children and adolescents, with trials designed to assess how well emerging therapies work and how safe they are.

  • Testing treatments for moderately to severely active pediatric Crohn's disease
  • Assessing treatment response in patients who have not benefited from standard therapies

These studies help advance care for young people facing persistent intestinal inflammation.

Rare Genetic and Growth Disorder Research

Research in congenital, hereditary, and neonatal diseases at this Prague hospital includes studies in osteochondrodysplasia, particularly achondroplasia, with a focus on safety and early treatment evaluation.

  • Studying therapies for children with rare skeletal growth disorders
  • Exploring whether new approaches may support better disease management and functional outcomes

This work reflects a strong interest in rare pediatric conditions and inherited disorders.

Broader Immune and Developmental Research

Beyond the main diseases studied, the clinical program covers immune system processes and related pediatric conditions, showing a broad interest in how inflammation and development affect child health.

  • Investigating therapies that may improve control of immune-mediated disease
  • Supporting research into pediatric conditions with complex developmental and inflammatory features

With a large investigator base, the department contributes to a diverse portfolio of clinical research in children.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Karlovo Namesti 554/32, Nove Mesto120 00 PragueCzechia
Recruiting now
150 trials
Conditions studied
183
Partner status
Verified

More sites in PragueCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

403 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:VISUGROMAB
  • Sponsor:CatalYm GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).